The company, founded in 2013, operates as a contextual knowledge hub, facilitating the effective connection and utilization of external and internal genomic information for pharma, biotech, and diagnostic organizations. SolveBio's genomic intelligence platform enables clients to manage, distribute, and access genomic reference data at scale, integrating valuable third-party information assets in real-time. By connecting complex genomic data from various sources, SolveBio empowers biopharma customers to reduce trial risk, develop more effective therapeutics, and accelerate clinical development. With support from prominent investors and an advisory board consisting of industry experts, SolveBio leads the way in advanced precision medicine data analytics.